Among the different PDE7 inhibitors reported in literature [8], phenyl-2-thioxo-(1H)-quinazolin-4-one, named S14 (Figure 1) [9], has shown a great potential to treat PD. The gene discussed is PDE7A; the disease is Parkinson disease.